Charles River CRO to Continue to Expand Biomanufacturing Support Biz

Media Coverage
biomanufacturing workers handling samples

BioProcess International

Contract Research Organization (CRO) Charles River reported full year 2018 revenues of $430 million (€381 million) within its manufacturing support division, up 11.9% on the previous year.

The unit provides manufacturing services for drug developers, including cell line characterization, lot release testing and stability studies. Increasingly, the business has focused on biologics, reflecting industry’s shifting pipelines, and so the CRO has been investing in this space.

Read the full story